Ignorant talk of “Boys using girls bathroom” illuminated by BBC doc “Me, My Sex and I”

Thursday, 28 February, 2013

Me My Sex And I - 2011 BBC doc

Two news items have been hotly discussed online recently:

New Massachusetts rules allow transgender students to choose their own bathroom“, Yahoo News (The Daily Caller), Feb 25, 2013

His or Hers? Transgender child locked in school bathroom debate“, CTV News, Feb 28, 2013

So I thought to spend a few minutes to look up an insightful documentary I watched in 2011 to try to illuminate the important issue that there are NO 100% male or 100% female. I am NOT 100% male. The real scientific reasoning is complex but not that difficult to understand. The human stories and the human impact take more compassion to appreciate and accept.

Here is the insightful BBC documentary “Me, My Sex and I” last broadcast on Oct, 2011. Someone posted the full documentary online that you can watch (video is flipped but you can still get most of the important points).

NOTE: I moderate comments on this post, any comments that appear to be made without watching the documentary or understanding the issues first will be deleted.

Part 1 of 4 “Me, My Sex and I”

Part 2 of 4 “Me, My Sex and I”

Part 3 of 4 “Me, My Sex and I”

Part 4 of 4 “Me, My Sex and I”


Interview with Dr. Naweed Syed, Hotchkiss Brain Institute, Neurochip co-lead researcher

Friday, 17 August, 2012

Interview with Dr. Naweed Syed, Hotchkiss Brain Institute, Neurochip co-lead researcher

Earlier this month I had a fascinating interview with Dr. Naweed Syed, Hotchkiss Brain Institute, head of University of Calgary Department of Cell Biology and Anatomy. Dr. Syed is one of the lead researchers behind neurochip − “a microchip with the ability to monitor several functions of the brain.Neurochip is “a novel lab-on-a-chip technology that, through an ultra-sensitive component built directly on the microchip, also enables direct imaging of activity in brain cells.”

In one fascinating part of the interview, Dr. Syed talked about Parkinson’s patients who have really bad tremors and don’t respond to drugs anymore. Currently, surgeons insert a deep brain stimulation electrode to allow the patients to stimulate the electrode themselves which release dopamine to stop the tremors. Unfortunately, the electrode can continue to stimulate the brain cells beyond the limit. Resulting in what is known as excitotoxicity. (Too much dopamine constantly being produced and brain cells being over excited.) In essence, nobody is there to tell the electrode when the stimulation is enough and can be stopped to avoid damage because there is no loop going back to tell it. Dr. Syed suggests implanting a two-way link where machines (capacitors and transistors) and the brain cells can talk to each other to better control the stimulation loop and avoid/reduce the problem of excitotoxicity.

Have a watch of my extensive interview with Dr. Syed to hear of his explanations and the background info in his own words for the latest advancement in research in neurochip.

As an alumnus of University of Calgary, it makes me really proud to see cool research done in Calgary, Alberta. At the same time, near the end of the interview, I asked Dr. Syed about the challenges of getting the required funding for the research program to succeed and to keep doing cutting edge researches right here in Calgary. Given the achievements his team has made so far, I would hate to see any of these world class scientists leaving Canada to go to United States/China, etc because our three level of governments and private industry partners are not putting in the needed funding to keep doing these ground-breaking researches that can lead to better medical devices, better drugs, etc right in Calgary, Alberta, Canada.

On a personal note, a very close friend has Parkinson’s and I hope the device Dr. Syed talked about can be developed, tested, and approved soon so that my friend and other Parkinson’s patients can benefit.

News references:

University of Calgary, UToday “New advances for neurochip

CTV News (with video), “U of C researchers achieve major milestone

Calgary Herald, “New microchip helps take detailed images of brain – University of Calgary researchers achieve new milestone


Investigating the truth behind sports drinks

Wednesday, 1 August, 2012

Just in time for London Olympics 2012. Great investigative work to find out “the truth behind sports drinks” by Rhodes Scholarship recipient Braden O’Neill (a third-year MD student at the University of Calgary currently on a leave of absence to study at the University of Oxford’s Centre for Evidence-Based Medicine in the Department of Primary Care Health Sciences). Excerpt from “Investigating the truth behind sports drinks”,

“Whether it’s ‘faster, stronger, for longer’, ‘enhances recovery’, or ‘gives you that extra boost’, sports product marketing is everywhere. Even the official drink of the Olympics this year is Powerade, whose ads claim that ‘Water is Not Enough’.

One of the research groups I work with here – the Centre for Evidence-Based Medicine – recently completed a study on sports performance products which I had the great privilege of being a part of. What we found didn’t quite support all those bold claims.”


Millions of cancer-free stem cells cultivated in days using new U of Calgary discovered method

Friday, 25 May, 2012

cancer-free stem cells cultivated by the millions using new U of Calgary developed method - pix 01cancer-free stem cells cultivated by the millions using new U of Calgary developed method - pix 02

cancer-free stem cells cultivated by the millions using new U of Calgary developed method - pix 03cancer-free stem cells cultivated by the millions using new U of Calgary developed method - pix 04

As a University of Calgary alumnus, it is exciting to see ground breaking research coming out of my alma mater. Quoting CBC News, “‘Safe’ stem cell discovery unveiled in Calgary – U of C researchers say they can create cancer-free cells quickly by the millions” (links and emphasis added)

“The findings by Derrick Rancourt and Roman Krawetz were published in the May issue of Nature Methods.

Rancourt said the discovery of a plentiful and reliable source of stem cells represents a great alternative to embryonic cells, the use of which is hotly debated.

With current methods, it takes one million adult cells to create one stem cell.

“In this new, finely tuned bioreactor, we are able to make 10 million ‘safe’ stem cells from 800,000 adult cells in 12 days,” said professor Rancourt, who is also deputy director of the McCaig Institute for Bone and Joint Health.

The researchers create the low risk stem cells by cultivating adult cells without the cancer gene ‘cMyc’, they said in a release.

“We are the first team to prove that we can use the bioreactor to efficiently make stem cells that then become mice without cancer,” said Krawetz.

The next stage will be to use the discovery to put human cells into the new bioreactors to design treatments for arthritis, Rancourt said.

Also have a watch of CTV News report, “Researchers mass produce super cells

Derrick Rancourt, PhD & Roman Krawetz, PhD: Bioreactor & Pluripotent Stem Cells

Interested readers can find a good literature review from Dr. Mehdi Shafa’s (one of the paper’s contributors) April 2012 PhD thesis Reprogramming of Mouse Fibroblasts to iPS Cells in Stirred Suspension Bioreactors using Physical and Genetic Methods” (PDF file).

cancer-free stem cells cultivated by the millions using new U of Calgary developed method - pix 05


‪Suzanne Somers‬ discusses regrowing her breast (FDA-trial) after lumpectomy

Tuesday, 22 May, 2012

Suzanne Somers - pix 01

Suzanne Somers‬ is best know as Chrissy Snow in Three’s Company, sex symbol, and in recent years an advocate for alternative medical treatments. This reporter has the pleasure of chatting with Somers‬ in a Fox LA Google+ Hangout few days ago. Somers‬ talked about having breast cancer, had a lumpectomy, and then earlier this year underwent a new (and controversial) procedure of regrowing her breast using her own stem cell.

Suzanne Somers‬ Fox LA Google+ Hangout

During the Fox LA G+ Hangout, this reporter asked and Somers‬ confirmed that she is the first woman in United States to undergo the procedure to regrow breast, performed by an American doctor, and most importantly, in an FDA-approved clinical trial. Upon further research, this reporter found that Somers‬ also talked to CNN Anderson Cooper about the new procedure as seen in this video.

Anderson Cooper‘s show segment Suzanne Somers on New Procedure for Breast Cancer Patients

In this MSNBC Today show report Somers said (emphasis and link added),

“Well, I lost my breast to — most of my breast to cancer 11 years ago. It was called a lumpectomy, but when they took the bandages off it was rather shocking. And I heard that Dr. Kotaro Yoshimura in the University of Tokyo had successfully regrown the breasts of 400 Japanese women. So I brought him over, put him together with a doctor in Los Angeles . We applied for an IRB , which is an institutional revue board, which qualifies me for a clinical trial.”

Note: - In 2007, BBC reported, “Kotaro Yoshimura, a surgeon at the Tokyo University medical school, said more than 40 patients had been treated.

- Here is a Wikipedia page for institutional review board.

See also this People Magazine report.

Cautions & Warnings

This reporter wants to make it clear that this report and Somers‬‘ personal experience should NOT be taken blindly as advice, or worst, as medical advice. It is extremely important to seek proper medical advice from licensed medical doctors/surgeons to help you understand the full risks vs. benefits of any new medical procedures.

Deep down, this reporter wants to be optimistic and hope that new procedure can help survivers of breast cancer. At the same time, this reporter is obliged to suggest and interested readers to read this serious cautioning NYT article by Barron H. Lerner, M.D., professor of medicine and public health at Columbia University Medical Center.

Note: This article is cross-posted on Examiner.com.


Jeff Chiba Stearns “Mixed Match” doc interview – mixed/multiethnic people’s additional challenges when dealing with life threatening blood diseases such as leukemia

Thursday, 5 April, 2012

Mixed Match - pix 01 - Maya Family and Rosanna

I first interviewed the award-winning filmmaker Jeff Chiba Stearns when he came to Calgary with his last film in 2010. Today, I had the pleasure to interview Jeff again to talk about his latest documentary Mixed Match, mixed/multiethnic people’s additional challenges when dealing with life threatening blood diseases such as leukemia, and how can we help.

Here is my video interview with Jeff Chiba Stearns, director of Mixed Match.

Because of the under representation of mixed/multiethnic/ethic people in the national bone marrow registries, please join the registry in Canada (OneMatch Stem Cell and Marrow Network) or United States (Be The Match Registry).

Mixed Match - pix 05 - One_Match_Drive

Mixed Match - pix 06 - Jeff_joining_registry

Have a read of the myths & facts about Bone Marrow Donation to dispel myths like

“Donating is painful and involves a long recovery.”

“All bone marrow donations involve surgery.”

To raise the needed funds to complete the film, Jeff has a crowdfunding page for Mixed Match on indiegogo. So far $5,340 has been raised towards his $25,000 funding goal. Please consider helping him finish Mixed Match by donating before April 27, 2012.

Mixed Match - pix 04 - Valerie_Sun_Interview2

Mixed Match - pix 02 - Maga_Hospital_Still1

Mixed Match - pix 07 - Krissy with Jeff and Athena

More photos here.


Interview with Maya Posch, an intersex person, re Netherlands court’s decision to let her officially change her gender to female

Friday, 30 March, 2012

Interview with Maya Posch, an intersex person, re Netherlands court’s decision to let her officially change her gender to female

Here is my video Interview with Maya Posch, an intersex person, re court’s decision to change her gender to female.

See Maya’s original news announcement. Check out more Google+ posts from Maya.


Danny Hillis TED Talk old and new

Sunday, 5 February, 2012

Danny Hillis of Applied Minds (company) is a really cool and interesting inventor and entrepreneur. Danny was a really good friend of Feynman and worked with him. The following TED talks are quite interesting and insightful.

Danny Hillis: Back to the future (of 1994)

Danny Hillis: Understanding cancer through proteomics (2011) Hmmm, proteomics looks cool.


Cardiac rehabilitation most effective immediately following heart attack

Thursday, 27 October, 2011

A healthy heart is important to us all and especially key for people that have a heart attack. I’ve added emphasis to the following article. [HT Marta]

October 27, 2011
Cardiac rehabilitation most effective immediately following heart attack

By Kathryn Sloniowski

Calgary, AB –New research from the University of Calgary’s Faculty of Medicine has found that patients who have experienced a heart attack are more likely to participate in, and complete a cardiac rehabilitation program when they have access to it within 14 days of hospital discharge. Cardiac rehabilitation is a series of educational and exercise components aimed at teaching participants how to live a healthier lifestyle, subsequently reducing risk factors for future heart related illness. Components include topics such as nutrition, physical fitness and mental wellness.

“The proven benefits of participation in cardiac rehabilitation are multi-faceted,” says Dr. James Stone, co-author of the study and member of the University’s Libin Cardiovascular Institute of Alberta. “They include living longer, less-frequent hospital admissions, requiring fewer heart procedures and having better control of the risk factors that cause coronary artery disease.”

The study, published in this month’s issue of Canadian Journal of Cardiology, included a total of 469 patients, Read the rest of this entry »


Intravenously-delivered viral therapy JX-594 consistently and selectively replicate in cancer tissue without harming normal tissues in humans

Thursday, 1 September, 2011

Dr. John Bell (Wikipedia) is a senior OHRI (Ottawa Hospital Research Institute) scientist and senior co-author of the publication in the journal Nature. Check out t a quicktime video of a three-dimensional reconstruction of part of a human colorectal tumour showing widespread infection with oncolytic vaccinia virus (green). Here is an excerpt from the OHRI press release (emphasis added),

“Researchers [...] today reported promising results of a world-first cancer therapy trial in renowned journal Nature. The trial is the first to show that an intravenously-delivered viral therapy can consistently infect and spread within tumours without harming normal tissues in humans. It is also the first to show tumour-selective expression of a foreign gene after intravenous delivery.

The trial involved 23 patients (including seven at The Ottawa Hospital), all with advanced cancers that had spread to multiple organs and failed to respond to standard treatments. The patients received a single intravenous infusion of a virus called JX-594, at one of five dose levels, and biopsies were obtained eight to 10 days later. Seven of eight patients (87 per cent) in the two highest dose groups had evidence of viral replication in their tumour, but not in normal tissues. All of these patients also showed tumour-selective expression of a foreign gene that was engineered into the virus to help with detection. The virus was well tolerated at all dose levels, with the most common side effect being mild to moderate flu-like symptoms that lasted less than one day.

“We are very excited because this is the first time in medical history that a viral therapy has been shown to consistently and selectively replicate in cancer tissue after intravenous infusion in humans,” said Dr. John Bell, a Senior Scientist at OHRI, Professor of Medicine at uOttawa and senior co-author on the publication. “Intravenous delivery is crucial for cancer treatment because it allows us to target tumours throughout the body as opposed to just those that we can directly inject. The study is also important because it shows that we can use this approach to selectively express foreign genes in tumours, opening the door to a whole new suite of targeted cancer therapies.””

Media reports:

CBC, “Intravenous virus eyed as possible cancer treatment

CTV, “Groundbreaking Ottawa-based cancer trials show “promising” results


Printing a human kidney using a 3D Printer

Saturday, 27 August, 2011

TED Talk: Anthony Atala: Printing a human kidney This is very cool. Highly recommended. [HT Andrew Mirasol]


Health Canada approved iPhone/iPad app for stroke diagnosis

Monday, 9 May, 2011

Health Canada approved iPhone/iPad app for stroke diagnosis

CTV News has done a great report where you can see the app in action.

“”In a medical emergency, medical imaging plays a critical role in diagnosis and treatment, time is critical in acute stroke care, every minute counts.” said Dr. Mitchell who is from the University of Calgary’s Faculty of Medicine.”

CBC also has a report that is worth a watch.

“”Now a physician anywhere can get a call on their iPhone and can immediately take a look at the images in the remote community,” said Ross Mitchell, a professor of radiology at the university who helped develop the software. “They can do more than just look at them. They can cut into them, rotate it in 3D, they can do all kinds of advanced visualizations and analysis, which may be critical to make the diagnosis.“”

Feels great to see some cutting edge tool developed in Calgary. From the University of Calgary, Faculty of Medicine press release,

“New research from the University of Calgary’s Faculty of Medicine shows that doctors can make a stroke diagnosis using an iPhone application with the same accuracy as a diagnosis at a medical computer workstation. This technology can be particularly useful in rural medical settings. This allows for real-time access to specialists such as neurologists, regardless of where the physicians and patients are located”

Here is the original JMIR (Journal of Medical Internet Research) technical paper, “A Smartphone Client-Server Teleradiology System for Primary Diagnosis of Acute Stroke“.

Discussion & Note

Not to take away from the significance and importance of team’s achievement, there are limitations in using the system over 3G network due to data transfer rate issues as indicated in the technical paper.

“The system should provide practical frame rates over cellular or wireless networks. In our experience, a single visualization server can accommodate 10 or more simultaneous iOS device users and is capable of delivering and displaying up to 14 frames per second on an iOS device connected over a 802.11g Wi-Fi network. The frame rate was enough to provide sufficient interactivity for comfortable use. However, the frame rate on a 3G cellular network was 1 to 4 frames per second, which was insufficient for practical use. We know that fourth generation (4G) cellular networks are now installed in many metropolitan centers. We estimate that the higher bandwidth of these new cellular networks should allow 10 to 15 frames per second to be delivered to smartphones. However, currently only the iPhone 4 and a few Android-based smartphones are capable of utilizing greater network bandwidth.”


Worth Reading: Some cancer cells are mortal, Self-healing plastic, Genes from algae allow blind mice to see

Thursday, 21 April, 2011

* New Scientist, ”Immortality of all cancer cells exposed as a myth” Here is an excerpt,

“Far from being immortal, most cancer cells seem unable to multiply limitlessly and spread throughout the body.

Dot Bennett of St George’s University of London and colleagues found that only four of 37 skin cancer samples they examined displayed the supposed hallmark of cancer. “We thought they’d all be immortal, but they weren’t,” she says.

By studying the molecular profiles of the cancer cells as they grew in the lab, the team found that many appeared to have hit a “telomere crisis” and stopped dividing. Telomeres are the caps that protect the ends of chromosomes and they shorten every time a cell divides. In a telomere crisis, the tips become so short that the cell mistakes them for DNA breaks and tries to repair them, generating freak cells that die or become dormant.”

* New Scientist, “Self-healing plastic fixed with a laser’s light touch” Here is an excerpt,

“Unlike regular polymers like the polystyrene that vending machines cups are made from, or the clear polycarbonate that CDs are pressed with, the molecules in the new rubbery polymers are not linked by strong covalent bonds – which involve atoms sharing electrons. Read the rest of this entry »


Worth Reading: Michael Douglas headlines fundraiser for McGill, Berkshire Hathaway Insider Trading/Shareholder Suit, Herzog/McCarthy/Krauss talk science & art

Tuesday, 19 April, 2011

* CBC News, “Michael Douglas began cancer journey in Canada – Star will headline Montreal fundraiser for head and neck cancer

* Alice Schroeder, Berkshire Hathaway Insider Trading, Shareholder Suit [Here is a link to the shareholder suit filing http://www.scribd.com/doc/53362856/kirby-v-sokol]

* Filmmaker Werner Herzog, novelist Cormac McCarthy, and physicist Lawrence Krauss talk about the connection between science and art (NPR Science Friday).


Orgasm Inc. in theaters in New York, Chicago, Ottawa, and more

Wednesday, 16 February, 2011

Orgasm Inc. - The Strange Science of Female Pleasure

I am happy to report the internationally widely acclaimed documentary Orgasm Inc by director Liz Canner is opening in theaters in New York City, Chicago and other US cities, and Ottawa in Canada.

Have a look of my video interview with Liz and what I’ve learned from the doc. Also check out TIME magazine “Warning: Orgasm, Inc. Will Leave You Hot and Bothered“.

Cities and screening dates listed on Orgasm Inc. website (retrieved on Feb 16, 2011):

New York City, NY • QUAD CINEMA • February 11th – Feb 24th, 2011
Chicago, IL • Gene Siskel Film Center • Opens February 11, 2011
Ottawa, ON • Mayfair Theatre • February 18, 19 & 22, 2011
Coral Gables, FL • Coral Gables Art Cinema • February 18 – 24, 2011

Charlotte, NC • McColl Center for Visual Art • March 2, 2011
Brookline, MA • Coolidge Corner Theatre • Opens March 24* – 31, 2011
* Run begins 3/25, with a “special evening” with the filmmaker on 3/24

Los Angeles, CA • Laemmle’s Sunset 5 • Opens April 1, 2011
San Francisco, CA • Roxie Theater • April 1 – 7, 2011
Albuquerque, NM • Guild Cinema • April 17 – 19, 2011
Ellsworth, ME • The Grand Auditorium • April 25, 2011

The Buzz listed on Orgasm Inc. website (retrieved on Feb 16, 2011):

“I loved Orgasm Inc. It’s a great combination of educational, entertaining and angering — perfect.”
-Gloria Steinem

“An extraordinary and revelatory documentary about female desire and the pharmaceutical industry.”
-The Times (UK) Read the rest of this entry »


Superbugs in supermarket chicken

Thursday, 10 February, 2011

CBC News, “Supermarket chicken harbours superbugs“.


Vitaminwater: 33 gram of sugar and (not) nutritious

Thursday, 20 January, 2011

From TorStar “Vitaminwater: Delicious and (not) nutritious“,

“The Vitaminwater label lists the amounts of specific medicinal ingredients in the beverage but only lists the presence of non-medicinal ingredients (like cane sugar and citric acid) and not how much has been added.

In reality, a 591 ml bottle of Vitaminwater contains about 33 grams of sugar, while a 355 ml can of Coke contains 39 grams.

The label on a bottle of Vitaminwater recommends drinking “one or two . . . bottles per day as needed.””

CBC News, “Coke Vitaminwater ad broke rules: U.K. watchdog – Company ordered not to market sugar-laden line as ‘nutritious’


U of C researchers may have unlocked clue in MS mystery

Thursday, 13 January, 2011

Have a look of Calgary Herald article, “U of C researchers may have unlocked clue in MS mystery“.

Also see abstract of the research article in Journal of Neuroscience, “EMMPRIN: A Novel Regulator of Leukocyte Transmigration into the CNS in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis“.


Andrew Wakefield, Autism-Vaccine Scare

Thursday, 13 January, 2011

Shocking research and reports. Brian Deer has done a great job in uncovering the truth about this autism-vaccine scare scandal. Unfortunately, what we learn here should serve as a serious warning for journalists or general public when we read medical news/research to be a little bit skeptical, even when the researches are published in supposedly “authoritative” medical journals like The Lancet.

BMJ, “How the case against the MMR vaccine was fixed” by Brian Deer (Part 1 of 2 “Secrets of the MMR scare”) Here is an excerpt,

“The journal [Lancet], meanwhile, took 12 years to retract the paper, by which time its mischief had been exported. As parents’ confidence slowly returned in Britain, the scare took off around the world, unleashing fear, guilt, and infectious diseases—and fuelling suspicion of vaccines in general.

BMJ, “How the vaccine crisis was meant to make money” by Brian Deer (Part 2 of 2 “Secrets of the MMR scare”)

* UK Guardian, “The medical establishment shielded Andrew Wakefield from fraud claims – Brian Deer spent years investigating Andrew Wakefield’s MMR and autism research, which he now alleges was fraudulent. Here he argues that doctors closed ranks behind one of their own

* NPR, “Journal Claims Profit Motive Helped Fuel Autism-Vaccine Scare

* “Wakefield Debunked, But Vaccine Fear Lives

* “Autism ‘study’ represents a failure of journalism


A tool that finds 3x more breast tumors, and why it’s not available to you

Tuesday, 11 January, 2011

A very insightful TEDWomen presentation from Deborah J. Rhodes, M.D. at Mayo Clinic, “A tool that finds 3x more breast tumors, and why it’s not available to you“.

Here is a link to the abstract of an article referenced by Dr. Rhodes in January 2011 Radiology, 258, 106-118 “Dedicated Dual-Head Gamma Imaging for Breast Cancer Screening in Women with Mammographically Dense Breasts” by Deborah J. Rhodes, MD, Carrie B. Hruska, PhD, Stephen W. Phillips, MD1, Dana H. Whaley, MD and Michael K. O’Connor, PhD


Follow

Get every new post delivered to your Inbox.

Join 605 other followers

%d bloggers like this: